PMD logo

Psychemedics (PMD) Company Overview

Profile

Full Name:

Psychemedics Corporation

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

January 22, 1987

Indexes:

Not included

Website:

http://www.psychemedics.com

Description:

Psychemedics Corporation specializes in drug testing using hair analysis. Their innovative technology helps detect substance abuse by analyzing hair samples, providing accurate and reliable results. This service is used by employers, schools, and healthcare providers to promote safety and well-being in various environments.

Key Details

Price

$2.25

Market Cap

$13.26 M(Small cap)

Last Dividend

$0.07

TTM Dividend Yield

-

Annual Revenue

$22.10 M(-12.45% YoY)

Annual EPS

-$0.72(-278.95% YoY)

PE Ratio

-

Annual ROE

-47.63%

Annual Debt To Equity

0.05

Beta

0.91

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

May 24, 2023
Splits

Next split:

N/A

Recent split:

Aug 1, 2002

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with PMD included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
Stocks below SMA 200
Stocks above SMA 50
Healthcare sector
All stocks
Small cap stocks
Moving average channel strategy
Diagnostics & Research industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.25
PMD price is $2.25

Price All-time High

$34.95
PMD price is currently -93.56% below its historical high of $34.95

Price Analysts Target

-
PMD price consensus analysts' forecast is unknown

Price Most Recent Change

0%
PMD {parameterFullLabel} has remained unchanged on Feb 27, 2025

Price YTD Change

+0.45%
PMD price is up +0.45% since January 1st

Price 3-Year Change

-67.34%
PMD price is down -67.34% over the past 3 years

Market cap

Market Cap

$13.26 M
PMD market capitalization is $13.26 million

Market Cap 3-Year Change

-65.56%
PMD market capitalization is down -65.56% over the past 3 years

Market Cap All-time High

$186.28 M
PMD market capitalization is currently -92.88% below its historical high of $186.28 million

Market Cap Sector Rank

20.46%
PMD market capitalization is higher than 20.46% of companies in Healthcare sector

Technical

Beta

0.91
PMD beta is 0.91

200-day SMA

$2.27
PMD price is currently -0.92% below its 200-day simple moving average

14-day RSI

52.63
PMD 14-day relative strength index is 52.63

30-day Relative Volume

2.24
PMD 30-day relative volume is 2.24

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.07
PMD last dividend was $0.07 per share, with an ex-dividend date of May 24, 2023

Next Dividend

-
PMD next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$0.28
PMD annual dividend per share is $0.28

Annual Dividend Per Share Sector Rank

13.41%
PMD annual dividend per share is higher than 13.41% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

+33.33%
PMD annual dividend per share is up +33.33% year-on-year

Annual Dividend Per Share 3-Year Change

-61.11%
PMD annual dividend per share is down -61.11% over the past 3 years

Dividend yield

Annual Dividend Yield

12.44%
PMD annual dividend yield is 12.44%

Annual Dividend Yield Sector Rank

96.3%
PMD annual dividend yield is higher than 96.3% of companies in Healthcare sector

Other

Annual Payout Ratio

-19.23%
PMD annual payout ratio is -19.23%

Annual Dividends Paid

$799.00 K
PMD annual dividends paid is $799.00 thousand

Annual FCF

-$1.64 M
PMD annual free cash flow is -$1.64 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$22.10 M
PMD annual revenue is $22.10 million

Annual Revenue Analysts Estimate

-
PMD annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-12.45%
PMD annual revenue is down -12.45% year-on-year

Annual Revenue Sector Rank

37.56%
PMD annual revenue is higher than 37.56% of companies in Healthcare sector

Profit

Annual Gross Profit

$8.41 M
PMD annual gross profit is $8.41 million

Annual Gross Margin

38.07%
PMD annual gross profit margin is 38.07%

Annual Operating Profit

-$2.92 M
PMD annual operating income is -$2.92 million

Annual Operating Margin

-13.22%
PMD annual operating profit margin is -13.22%

Annual Net Income

-$4.15 M
PMD annual net profit is -$4.15 million

Annual Net Margin

-18.80%
PMD annual net profit margin is -18.80%

EPS

Annual EPS

-$0.72
PMD annual earnings per share is -$0.72

Annual EPS Analysts Estimate

-
PMD annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-278.95%
PMD annual earnings per share is down -278.95% year-on-year

Annual EPS Sector Rank

65.76%
PMD annual earnings per share is higher than 65.76% of companies in Healthcare sector

ROA & ROE

Annual ROA

-26.75%
PMD annual return on assets is -26.75%

Annual ROE

-47.63%
PMD annual return on equity is -47.63%

EBIT & EBITDA

Annual EBIT

-$2.92 M
PMD annual earnings before interest & taxes is -$2.92 million

Annual EBITDA

-$251.00 K
PMD annual EBITDA is -$251.00 thousand

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
PMD price to earnings ratio value is unknown

PE Ratio Sector Rank

-
PMD price to earnings ratio is unknown

PB Ratio

PB Ratio

2.44
PMD price to book ratio is 2.44

PB Ratio Sector Rank

64.38%
PMD price to book ratio is higher than 64.38% of companies in Healthcare sector

PS Ratio

PS Ratio

0.65
PMD price to sales ratio is 0.65

PS Ratio Sector Rank

18.34%
PMD price to sales ratio is higher than 18.34% of companies in Healthcare sector

Enterprise value

Enterprise Value

$13.44 M
PMD enterprise value is $13.44 million

Enterprise Value Sector Rank

25.8%
PMD enterprise value is higher than 25.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-19.59
PMD EV/EBITDA is -19.59

EV/EBITDA Sector Rank

6.9%
PMD EV/EBITDA is higher than 6.9% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.45
PMD annual current ratio is 1.45

Annual Quick Ratio

-
PMD annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.05
PMD annual debt to equity ratio is 0.05

Annual Interest Coverage Ratio

-
PMD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

6
PMD piotroski f-score is 6

Altman Z-Score

0.72
PMD altman z-score is 0.72

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$12.33 M
PMD annual total assets is $12.33 million

Annual Non Current Assets

$5.52 M
PMD annual long term assets is $5.52 million

Annual Current Assets

$6.80 M
PMD annual total current assets is $6.80 million

Annual Cash & Cash Equivalents

$1.96 M
PMD annual cash & cash equivalents is $1.96 million

Equity

Annual Book Value

$6.67 M
PMD annual book value is $6.67 million

Annual Working Capital

$2.10 M
PMD annual working capital is $2.10 million

Liabilities

Annual Total Liabilities

$5.65 M
PMD annual total liabilities is $5.65 million

Annual Total Long Term Liabilities

$945.00 K
PMD annual total long term liabilities is $945.00 thousand

Annual Current Liabilities

$4.71 M
PMD annual total current liabilities is $4.71 million

Annual Accounts Payable

$752.00 K
PMD annual accounts payable is $752.00 thousand

Debt

Annual Total Debt

$2.30 M
PMD annual total debt is $2.30 million

Annual Total Debt 1-Year Change

-35.7%
PMD annual total debt is down -35.7% year-on-year

Annual Long Term Debt

$945.00 K
PMD annual long term debt is $945.00 thousand

Annual Short Term Debt

$1.35 M
PMD annual short term debt is $1.35 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$25.02 M
PMD annual total expenses is $25.02 million

Annual Operating Expenses

$11.33 M
PMD annual total operating expenses is $11.33 million

Annual Cost Of Goods Sold

$13.69 M
PMD annual cost of goods sold is $13.69 million

Annual SGA

$10.19 M
PMD annual SGA is $10.19 million

Annual D&A

$2.67 M
PMD annual depreciation & amortization is $2.67 million

Annual Interest Expense

-
PMD annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$1.48 M
PMD annual cash flow from operations is -$1.48 million

Annual CFO 1-Year Change

-130.27%
PMD annual cash flow from operations is down -130.27% year-on-year

Annual CFI

-$159.00 K
PMD annual cash flow from investing activities is -$159.00 thousand

Annual CFI 1-Year Change

+23.56%
PMD annual cash flow from investing activities is up +23.56% year-on-year

Annual CFF

-$1.15 M
PMD annual cash flow from financing activities is -$1.15 million

Annual CFF 1-Year Change

+40.38%
PMD annual cash flow from financing activities is up +40.38% year-on-year

Free CashFlow

Annual FCF

-$1.64 M
PMD annual free cash flow is -$1.64 million

Annual FCF 1-Year Change

-134.81%
PMD annual free cash flow is down -134.81% year-on-year

CAPEX

Annual CAPEX

$157.00 K
PMD annual capital expenditures is $157.00 thousand

Annual CAPEX 1-Year Change

-16.04%
PMD annual capital expenditures is down -16.04% year-on-year

Institutional Ownership

Similar stocks

CHRO logo
Chromocell Therapeutics (CHRO)
PHGE logo
BiomX (PHGE)
MYNZ logo
Mainz Biomed BV (MYNZ)
LYRA logo
Lyra Therapeutics (LYRA)
AXLA logo
Axcella Health (AXLA)
APRE logo
Aprea Therapeutics (APRE)
GOVX logo
GeoVax Labs (GOVX)
FBRX logo
Forte Biosciences (FBRX)
EVAX logo
Evaxion Biotech A/S (EVAX)

FAQ

  • What is the ticker symbol for Psychemedics?
  • Does Psychemedics pay dividends?
  • What sector is Psychemedics in?
  • What industry is Psychemedics in?
  • What country is Psychemedics based in?
  • When did Psychemedics go public?
  • Is Psychemedics in the S&P 500?
  • Is Psychemedics in the NASDAQ 100?
  • Is Psychemedics in the Dow Jones?
  • When was Psychemedics's last earnings report?
  • When does Psychemedics report earnings?

What is the ticker symbol for Psychemedics?

The ticker symbol for Psychemedics is NASDAQ:PMD

Does Psychemedics pay dividends?

No, Psychemedics does not pay dividends

What sector is Psychemedics in?

Psychemedics is in the Healthcare sector

What industry is Psychemedics in?

Psychemedics is in the Diagnostics & Research industry

What country is Psychemedics based in?

Psychemedics is headquartered in United States

When did Psychemedics go public?

Psychemedics's initial public offering (IPO) was on January 22, 1987

Is Psychemedics in the S&P 500?

No, Psychemedics is not included in the S&P 500 index

Is Psychemedics in the NASDAQ 100?

No, Psychemedics is not included in the NASDAQ 100 index

Is Psychemedics in the Dow Jones?

No, Psychemedics is not included in the Dow Jones index

When was Psychemedics's last earnings report?

Psychemedics's most recent earnings report was on Nov 12, 2024

When does Psychemedics report earnings?

The next expected earnings date for Psychemedics is Mar 28, 2025